High-density lipoproteins and COVID-19: preparing the next pandemic
Open Access
- 14 March 2025
- journal article
- review article
- Published by Elsevier in Journal of Lipid Research
- Vol. 66 (5) , 100779
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Adjunctive Statin Therapy in Patients with Covid-19: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsThe American Journal of Medicine, 2024
- The prognostic value of general laboratory testing in patients with COVID‐19Journal of Clinical Laboratory Analysis, 2020
- Alteration of lipid profile and value of lipids in the prediction of the length of hospital stay in COVID‐19 pneumonia patientsFood Science & Nutrition, 2020
- High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical VentilationObesity, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate SignalingInflammation, 2017
- The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesisAtherosclerosis, 2009
- Effects of Statins on High-Density Lipoproteins: A Potential Contribution to Cardiovascular BenefitCardiovascular Drugs and Therapy, 2008
- Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometryProteomics, 2005